Washington D.C.: There is an urgent need to monitor the heart of cancer patients, as physicians are not revealing them about the cardiotoxicity risks of treatments and may not be fully aware of the dangers themselves, suggest researchers.

The growing number of cancer survivors and the increasing number of chronic cancer therapy mean that the need for cardio-oncology services is rising. Heart failure caused by cancer therapy can occur up to 20 years after treatment, as per the details presented in The Meeting of EuroHeartCare.